Ajinomoto Co., Inc. has signed a licensing agreement with Astellas Pharma Inc. for the use of AJICAP—an antibody-drug conjugate (ADC) development and manufacturing technology—as part of its CDMO ...
IntoCell Inc. (KOSDAQ: 287840), a biotechnology company developing next-generation payload and linker technologies for antibody–drug conjugates (ADCs), and Xcellon Biologics, a U.S.-based contract ...
The integrated half-bridges enable direct drive of DC, BLDC and stepper motors, controlled through Hall sensors or BEMF (back EMF) signal evaluation. A 12-bit ADC resolution, 16-bit timers, PWM ...
WaveLogic technology drives high-capacity, low-latency connectivity from cable landing station to PLDT’s national backbone network MANILA – ...
PLDT INC. hopes to enhance the Philippines’ domestic backhaul infrastructure through a partnership with US-based Ciena Corp., which will deploy advanced optical technology to improve data transmission ...
Thousand Oaks Biologics, a leading Asia-based CRDMO specializing in macromolecules, today announced its participation in CPHI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback